Abstract:Background: COVID-19 displays an increased mortality rate and higher risk of severe symptoms with increasing age, which is thought to be a result of the compromised immunity of elderly patients. However, the underlying mechanisms of aging-associated immunodeficiency against Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. Epigenetic modifications show considerable changes with age, causing altered gene regulations and cell functions during the aging process. The DNA methylation patterns among patients with coronavirus 2019 disease (COVID-19) who had different ages were compared to explore the effect of aging-associated methylation modifications in SARS-CoV-2 infection. Methods: Patients with COVID-19 were divided into three groups according to age. Boruta was used on the DNA methylation profiles of the patients to remove irrelevant features and retain essential signature sites to identify substantial aging-associated DNA methylation changes in COVID-19. Next, these features were ranked using the minimum redundancy maximum relevance (mRMR) method, and the feature list generated by mRMR was processed into the incremental feature selection method with decision tree (DT), random forest, k-nearest neighbor, and support vector machine to obtain the key methylation sites, optimal classifier, and decision rules. Results: Several key methylation sites that showed distinct patterns among the patients with COVID-19 who had different ages were identified, and these methylation modifications may play crucial roles in regulating immune cell functions. An optimal classifier was built based on selected methylation signatures, which can be useful to predict the aging-associated disease risk of COVID-19. Conclusions: Existing works and our predictions suggest that the methylation modifications of genes, such as NHLH2, ZEB2, NWD1, ELOVL2, FGGY, and FHL2, are closely associated with age in patients with COVID-19, and the 39 decision rules extracted with the optimal DT classifier provides quantitative context to the methylation modifications in elderly patients with COVID-19. Our findings contribute to the understanding of the epigenetic regulations of aging-associated COVID-19 symptoms and provide the potential methylation targets for intervention strategies in elderly patients.

Exploring the correlation between DNA methylation and biological age using an interpretable machine learning framework

Human Age Prediction Based on DNA Methylation of Non-Blood Tissues

Age Prediction of Human Based on DNA Methylation by Blood Tissues

An age classification model based on DNA methylation biomarkers of aging in human peripheral blood using random forest and artificial neural network

A Comprehensive Assessment of Methylation-Based Age Prediction Methods

Human Age Prediction Based on DNA Methylation Using a Gradient Boosting Regressor.

DNA Methylome: Unveiling Your Biological Age

Chronological Age Prediction: Developmental Evaluation of DNA Methylation-Based Machine Learning Models

Assessment of DNA methylation from a single genomic region of ELOV2 is sufficient to predict chronological age

Predicting human age by detecting DNA methylation status in hair

Epigenetic Predictor of Age

Age Prediction based on Blood DNA Methylation

DNA methylation correlates of chronological age in diverse human tissue types

DeepAge: Harnessing Deep Neural Network for Epigenetic Age Estimation From DNA Methylation Data of human blood samples

DeepMAge: A Methylation Aging Clock Developed with Deep Learning

Age Prediction of Children and Adolescents Aged 6-17 Years: an Epigenome-Wide Analysis of DNA Methylation

Longitudinal prediction of DNA methylation to forecast epigenetic outcomes

DNA methylation clocks for estimating biological age in Chinese cohorts

Genome-wide association studies identify 137 loci for DNA methylation biomarkers of ageing

Studies of hTERT DNA methylation assays on the human age prediction

Identification of DNA Methylation Signature and Rules for SARS-CoV-2 Associated with Age